Rectum is the least common site of involvement by gastrointestinal lymphomas with Burkitt’s lymphoma subtype being even more infrequent, accounting for less than 0.0005% of all primary rectal malignancies. Significance lies in its rarity, the difficulty in distinguishing it from rectal carcinoma, and its not yet standardized treatment protocol. Here, we report a case of primary rectal Burkitt’s lymphoma in a 32-year male with Crohn’s disease on azathioprine, who was successfully managed with laparoscopic low anterior resection with adjuvant intensive chemotherapy. Our case attempts to shows that minimally invasive surgical resection with adjuvant chemotherapy is a viable therapeutic option for rectal lymphomas including the aggressive variants like Burkitt’s lymphoma.
Rectal lymphoma Burkitt’s lymphoma Rectal cancer Crohn’s disease Laparoscopy
This is a preview of subscription content, log in to check access.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Dodd GD (1990) Lymphoma of the hollow abdominal viscera. Radiol Clin N Am 28:771–783Google Scholar
Siegel CA (2009) Risk of lymphoma in inflammatory bowel disease. Gastroenterol Hepatol 5(11):784–790Google Scholar
Morrison VA (2008) Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma. Expert Rev Anticancer Ther 8:1651–1658CrossRefGoogle Scholar